1124-29-4

Usage

Uses

Used in Organic Synthesis:
2(1H)-Pyridinone, 5-acetyl(9CI) is used as a chemical intermediate for the synthesis of various organic compounds. Its presence in the pyridinone class allows it to participate in a range of chemical reactions, making it a valuable component in the development of new molecules and materials.
Used in Pharmaceutical Research:
2(1H)-Pyridinone, 5-acetyl(9CI) is used as a potential candidate in pharmaceutical research for the development of new drugs. Its unique structure and reactivity may contribute to the discovery of novel therapeutic agents, particularly in the areas of medicinal chemistry and drug design.
Used in Chemical Reactions:
2(1H)-Pyridinone, 5-acetyl(9CI) is used as a reactant in various chemical reactions, allowing for the formation of new compounds with potential applications in different industries. Its versatility in reacting with other molecules makes it a valuable tool in the field of organic chemistry.
Used in Material Science:
2(1H)-Pyridinone, 5-acetyl(9CI) is used in the development of new materials with specific properties, such as conductivity, stability, or reactivity. Its incorporation into materials may lead to advancements in areas like electronics, energy storage, or catalysis.
Note: The uses mentioned above are hypothetical and based on the general properties of pyridinones. The actual applications of 2(1H)-Pyridinone, 5-acetyl(9CI) may vary and depend on further research and development in the respective fields.

InChI:InChI=1/C7H7NO2/c1-5(9)6-2-3-7(10)8-4-6/h2-4H,1H3,(H,8,10)

Upstream product

• 14188-94-4 3-acetylpyridine N-oxide 
• 108-24-7 acetic anhydride 
• 350-03-8 methyl-3-pyridylketone 
• 213193-32-9 1‐(6‐methoxypyridin‐3‐yl)ethan‐1‐one 
• 13472-85-0 2-methoxy-5-bromopyridine 
• 858600-08-5 N,6-dimethoxy-N-methylpyridine-3-carboxamide 
• 66572-55-2 6-methoxynicotinic acid 

Downstream Products

• 325489-17-6 5-acetyl-1-(4-methylbenzenesulfonyl)-2(1H)-pyridone 
• 1590402-40-6 C₁₆H₁₇NO₃ 
• 1590402-61-1 C₁₃H₁₀FNO₂ 
• 381233-78-9 5-(2-Pyridyl)-1,2-dihydropyridin-2-one 
• 1571034-63-3 5-(1-(((4-methoxybenzyl)oxy)imino)ethyl)pyridin-2(1H)-one 
• 1571034-17-7 1-(6-oxo-1,6-dihydropyridin-3-yl)-3-(4-(trifluoromethoxy)phenyl)propane-1,3-dione 
• 1571034-60-0 1-(3-(4-(methylsulfonyl)piperidin-1-yl)benzyl)-5-(5-(4-(trifluoromethoxy)phenyl)isoxazol-3-yl)pyridin-2(1H)-one 
• 1571034-72-4 1-(3-bromobenzyl)-5-(5-(4-(trifluoromethoxy)phenyl)isoxazol-3-yl)pyridin-2(1H)-one 
• 1571034-24-6 5-(5-(4-(trifluoromethoxy)phenyl)isoxazol-3-yl)pyridin-2(1H)-one 
• 1571034-69-9 5-(1-(((4-methoxybenzyl)oxy)imino)-3-oxo-3-(4-(trifluoromethoxy)phenyl)propyl)pyridin-2(1H)-one 
• 1571034-66-6 5-(3-hydroxy-1-(((4-methoxybenzyl)oxy)imino)-3-(4-(trifluoromethoxy)phenyl)propyl)pyridin-2(1H)-one 
• 1571025-04-1 1-((2-(4-methylpiperazin-1-yl)pyridin-4-yl)methyl)-5-(5-(4-(trifluoromethoxy)phenyl)isoxazol-3-yl)pyridin-2(1H)-one 
• 1571034-27-9 1-((2-(4-methylpiperazin-1-yl)pyridin-4-yl)methyl)-5-(3-(4-(trifluoromethoxy)phenyl)isoxazol-5-yl)pyridin-2(1H)-one 
• 1571034-36-0 1-(1-((2-(4-methylpiperazin-1-yl)pyridin-4-yl)methyl)-6-oxo-1,6-dihydropyridin-3-yl)-3-(4-(trifluoromethoxy)phenyl)propane-1,3-dione 

Relevant academic research and scientific papers

An investigation of structure‐activity relationships of azolylacryloyl derivatives yielded potent and long‐acting hemoglobin modulators for reversing erythrocyte sickling

Aromatic aldehydes that bind to sickle hemoglobin (HbS) to increase the protein oxygen affinity and/or directly inhibit HbS polymer formation to prevent the pathological hypoxia‐induced HbS polymerization and the subsequent erythrocyte sickling have for s

ANTI-FIBROTIC PYRIDINONES

This application relates to polycyclic compounds with a pyridinone or pyridinone derivative core including, substituted pyridinones, 5,6- and 6,6- bicyclic heterocycles and substituted pyridine-thiones. This application also discloses methods of preparing these polycyclic compounds, pharmaceutical compositions and medicaments comprising said compounds and methods to treat, prevent or diagnose diseases, disorders or conditions associated with fibrosis.

SELECTIVE OCTAHYDRO-CYCLOPENTA[C] PYRROLE NEGATIVE MODULATORS OF NR2B

Compounds that selectively negatively modulate NMDA receptors containing an NR1/NR2B subunit, pharmaceutical compositions comprising the compounds, and methods of treating a disease using the compounds are disclosed. Such diseases include, without limitation, neurological dysfunction such as Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, multiple sclerosis, and seizure disorders; emotional disorders; depression; bipolar disorder; obsessive-compulsive disorder; and other anxiety disorders.

ANTI-FIBROTIC PYRIDINONES

Disclosed are pyridinone compounds, method for preparing these compounds, and methods for treating fibrotic disorders.

CHROMAN - SPIROCYCLIC PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS

The invention relates to chroman spirocyclic piperidine amide derivatives useful as inhibitors of ion channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.

Novel synthesis of tetrahydro-2(1H)-quinolones using Diels-Alder reactions of 1-arylsulfonyl-2(1H)-pyridones having an electron-withdrawing group

A novel synthetic methodology of preparing tetrahydro-2(1H)-quinolones by Diels-Alder reactions between 2-methyl- and 2,3-dimethyl-1,3-butadienes and 1-arylsulfonyl-2(1H)-pyridones having an electron-withdrawing group at the 5-position is presented. Furthermore, the site-selectivity analyses based on MO calculations of the 5-substituted 2(1H)-pyridones acting as the dienophiles are described.